1. Department of Malignant Hematology and
2. Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL;
3. Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan;
4. Department of Laboratory Medicine, Section of Hematology and Transfusion Medicine, Lund University, Lund, Sweden;
5. Stanley Center for Psychiatric Research and
6. Program in Medical and Population Genetics, Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, MA;
7. Department of Genetics, Harvard Medical School, Boston, MA;
8. Cote d’Azur University, Centre Hospitalier Universitaire of Nice, Nice, France;
9. Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford and Oxford Biomedical Research Centre Haematology Theme, Oxford, United Kingdom;
10. Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH;
11. Institut de Recerca Contra la Leucèmia Josep Carreras, Institut Catala d'Oncologia–Hospital GermansTrias i Pujol, Universitat Autonòma de Barcelona, Badalona, Barcelona, Spain;
12. Laboratori de Citologia Hematòlogica, Servei de Patologia, Hospital del Mar, Barcelona, Spain;
13. Department of Haematological Medicine, Kings College London, London, United Kingdom;
14. Senior Hematology Department, Hopital Saint Louis, Paris, France;
15. Departments of Medicine and Medical Oncology, Harvard Medical School and Brigham and Women’s Hospital, Boston, MA; and
16. Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL